---
schema_version: "secwatch.filing_event.v1"
accession: "0001411690-23-000067"
form_type: "8-K"
ticker: "BNGO"
cik: "0001411690"
company_name: "Bionano Genomics, Inc."
filed_at: "2023-08-09T23:59:59+00:00"
generated_at: "2026-06-11T21:44:28.388610+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Bionano Genomics Q2 revenue up 30% to $8.7M; flowcell sales more than double YoY

## Summary
- Q2 2023 revenue $8.7M, +30% YoY; GAAP gross margin 27% vs 22%.
- Installed Saphyr systems 281 (+43% YoY); flowcells sold 7,062 (+108% YoY).
- GAAP operating expense $41.5M vs $33.6M; non-GAAP opEx $34.6M.
- Cash & securities $77.1M at June 30, down from $95.8M at March 31.
- Announced Stratys high-throughput OGM system and VIA software for hematologic malignancies.

## SEC filing metadata
- accession: 0001411690-23-000067
- form_type: 8-K
- ticker: BNGO
- cik: 0001411690
- company_name: Bionano Genomics, Inc.
- filed_at: 2023-08-09T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1411690/000141169023000067/0001411690-23-000067-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1411690/000141169023000067/bngo-20230809.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001411690-23-000067
- JSON: https://secwatch.observer/filing/0001411690-23-000067.json
- Plain text: https://secwatch.observer/filing/0001411690-23-000067.txt

## Key facts
- Earnings Releases
  Bionano Genomics, Inc. reported second quarter ended June 30, 2023 results: revenue $8.7 million.
  - Period: second quarter ended June 30, 2023
  - Revenue: $8.7 million
  - Result: reported results
  source text: filing to this Current Report on Form 8-K. --- EX-99.1 (EX-99.1) --- Bionano Reports Second Quarter 2023 Results and Highlights Recent Business Progress • Q2 2023 revenue was $8.7 million, which represents a 30% increase over Q2 2022 • Installed base of Saphyr ® systems totaled 281 as of June 30, 2023, which represents a 43% increase over Q2 2022 • Sold 7,062
  evidence_url: https://www.sec.gov/Archives/edgar/data/1411690/000141169023000067/0001411690-23-000067-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.